PMM had a major revision in 2022 and aims to remain of relevance to the wider community to support educational activities.
PMM is for all clinicians who may encounter children and aims to raise awareness, knowledge and clinical skills to facilitate early diagnosis and referral, where necessary, to specialist care. PMM is recommended for PReS members to use in their teaching of medical students, paediatricians, family doctors and allied health professionals.
The CARRA JDM Disease Committee, with IMACS, would be very grateful if you could complete an important, voluntary IRB-approved survey to help us determine the worldwide applicability of the consensus guidelines for JDM for assessment and treatment (SHARE Guidelines https://ard.bmj.com/content/76/2/329). Please respond by August 30, 2022.
We are looking for EMERGE representatives to join the PRES Vaccination Working Party and JIA Working Party. Please send the application form below to emerge.pres@gmail.com, together with a CV (additional publication list is optional). Applicants should identify which WP they want to apply to in the topic of their application email. Deadline for applications is 15th August 2022.
The only constant in life is change and this is especially true for the dynamic members of the Task Force! Congratulations to Prof Claudia Saad-Maghalães from Brazil who has kindly agreed to replace Prof Helen Foster as Co-Chair on the Task Force.
This program is aimed at paediatric rheumatology trainees and young scientists who are members of PReS and younger than 45 years, allowing them to visit a Paediatric Rheumatology Centre within Europe for the period of up to 6 months.
Application deadline: 31 August 2022